中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2015年
9期
1287-1291
,共5页
石坤%王献民%乔莉娜%赵珊珊%陈婷婷%柳颐龄%李焰%周同甫
石坤%王獻民%喬莉娜%趙珊珊%陳婷婷%柳頤齡%李燄%週同甫
석곤%왕헌민%교리나%조산산%진정정%류이령%리염%주동보
血管重构%肺动脉%多西环素%明胶酶%鼠
血管重構%肺動脈%多西環素%明膠酶%鼠
혈관중구%폐동맥%다서배소%명효매%서
Vascular remodeling%Pulmonary artery%Doxycycline%Gelatinase%Rats
目的 研究小剂量多西环素对大鼠左肺切除后注射野百合碱所造成肺动脉重构及肺动脉高压的作用影响.方法 将45只健康雄性SD大鼠随机分为正常组(N组)15只、模型组(PM组)15只、小剂量多西环素干预组(PMD组)15只.5周后观察各组的血流动力学指标、肺动脉管壁厚度及肌性化程度比、肺动脉新生内膜形成情况、肺动脉管壁细胞增殖度及凋亡蛋白Caspase-3表达变化情况;免疫组化和RT-PCR检测明胶酶(包括MMP-2、9)及TIMP-1在肺组织中的表达水平变化;明胶酶谱法检测肺组织匀浆中明胶酶活性的变化情况.结果 (1)PM组肺动脉平均压为(38.89±1.68) mmHg,高于N组的(18.28±1.52) mmHg和PMD组的(29.89±1.75) mmHg(F=79.246,P<0.05).(2)PM组肺动脉管壁厚度比为(51.98±8.49)%,均高于N组的(10.97±3.22)%和PMD组的(26.19±3.10)% (F =58.439,P<0.05).(3)PM组凋亡蛋白Caspase-3的表达[(14.38±2.60) ×103]低于N组[(5.29±1.39) ×103]和PMD组[(25.81±6.14) ×103](F=58.421,P<0.05).(4)PM组新生内膜增殖比为(75.69±3.98)%,高于PMD组的(30.38±5.22)%(t=10.236,P<0.05),N组未见新生内膜形成.(5)PM组TIMP-1在肺组织中的表达定量均高于N组和PMD组(P<0.05),PM组MMP-2免疫组化表达[(59.61±13.01)×103]均高于N组[(3.78±2.18) ×103]和PMD组[(25.95.±6.89) ×103](F=76.484,P<0.05),PM组MMP-2 RT-PCR表达[(9.80±0.78)]均高于N组[(1.90±1.02)]和PMD组[(7.90±0.62)] (F =45.891,P<0.05).(6)PM组肺组织明胶酶活性测定[(4.89±0.29) ×103]均高于N组[(1.52±0.31) ×103]和PMD组[(2.87.±0.17) ×103](F=47.659,P<0.05).结论 小剂量多西环素能有效降低胶原酶在肺组织中的表达及活性,从而减轻实验性大鼠肺动脉重构,并降低其肺动脉压力.其机制可能与降低肺动脉管壁细胞增殖并诱导增生细胞凋亡、限制肺动脉平滑肌细胞迁移有关.该研究为今后小剂量多西环素作为金属基质蛋白酶抑制剂用于肺动脉高压的治疗提供了参考依据.
目的 研究小劑量多西環素對大鼠左肺切除後註射野百閤堿所造成肺動脈重構及肺動脈高壓的作用影響.方法 將45隻健康雄性SD大鼠隨機分為正常組(N組)15隻、模型組(PM組)15隻、小劑量多西環素榦預組(PMD組)15隻.5週後觀察各組的血流動力學指標、肺動脈管壁厚度及肌性化程度比、肺動脈新生內膜形成情況、肺動脈管壁細胞增殖度及凋亡蛋白Caspase-3錶達變化情況;免疫組化和RT-PCR檢測明膠酶(包括MMP-2、9)及TIMP-1在肺組織中的錶達水平變化;明膠酶譜法檢測肺組織勻漿中明膠酶活性的變化情況.結果 (1)PM組肺動脈平均壓為(38.89±1.68) mmHg,高于N組的(18.28±1.52) mmHg和PMD組的(29.89±1.75) mmHg(F=79.246,P<0.05).(2)PM組肺動脈管壁厚度比為(51.98±8.49)%,均高于N組的(10.97±3.22)%和PMD組的(26.19±3.10)% (F =58.439,P<0.05).(3)PM組凋亡蛋白Caspase-3的錶達[(14.38±2.60) ×103]低于N組[(5.29±1.39) ×103]和PMD組[(25.81±6.14) ×103](F=58.421,P<0.05).(4)PM組新生內膜增殖比為(75.69±3.98)%,高于PMD組的(30.38±5.22)%(t=10.236,P<0.05),N組未見新生內膜形成.(5)PM組TIMP-1在肺組織中的錶達定量均高于N組和PMD組(P<0.05),PM組MMP-2免疫組化錶達[(59.61±13.01)×103]均高于N組[(3.78±2.18) ×103]和PMD組[(25.95.±6.89) ×103](F=76.484,P<0.05),PM組MMP-2 RT-PCR錶達[(9.80±0.78)]均高于N組[(1.90±1.02)]和PMD組[(7.90±0.62)] (F =45.891,P<0.05).(6)PM組肺組織明膠酶活性測定[(4.89±0.29) ×103]均高于N組[(1.52±0.31) ×103]和PMD組[(2.87.±0.17) ×103](F=47.659,P<0.05).結論 小劑量多西環素能有效降低膠原酶在肺組織中的錶達及活性,從而減輕實驗性大鼠肺動脈重構,併降低其肺動脈壓力.其機製可能與降低肺動脈管壁細胞增殖併誘導增生細胞凋亡、限製肺動脈平滑肌細胞遷移有關.該研究為今後小劑量多西環素作為金屬基質蛋白酶抑製劑用于肺動脈高壓的治療提供瞭參攷依據.
목적 연구소제량다서배소대대서좌폐절제후주사야백합감소조성폐동맥중구급폐동맥고압적작용영향.방법 장45지건강웅성SD대서수궤분위정상조(N조)15지、모형조(PM조)15지、소제량다서배소간예조(PMD조)15지.5주후관찰각조적혈류동역학지표、폐동맥관벽후도급기성화정도비、폐동맥신생내막형성정황、폐동맥관벽세포증식도급조망단백Caspase-3표체변화정황;면역조화화RT-PCR검측명효매(포괄MMP-2、9)급TIMP-1재폐조직중적표체수평변화;명효매보법검측폐조직균장중명효매활성적변화정황.결과 (1)PM조폐동맥평균압위(38.89±1.68) mmHg,고우N조적(18.28±1.52) mmHg화PMD조적(29.89±1.75) mmHg(F=79.246,P<0.05).(2)PM조폐동맥관벽후도비위(51.98±8.49)%,균고우N조적(10.97±3.22)%화PMD조적(26.19±3.10)% (F =58.439,P<0.05).(3)PM조조망단백Caspase-3적표체[(14.38±2.60) ×103]저우N조[(5.29±1.39) ×103]화PMD조[(25.81±6.14) ×103](F=58.421,P<0.05).(4)PM조신생내막증식비위(75.69±3.98)%,고우PMD조적(30.38±5.22)%(t=10.236,P<0.05),N조미견신생내막형성.(5)PM조TIMP-1재폐조직중적표체정량균고우N조화PMD조(P<0.05),PM조MMP-2면역조화표체[(59.61±13.01)×103]균고우N조[(3.78±2.18) ×103]화PMD조[(25.95.±6.89) ×103](F=76.484,P<0.05),PM조MMP-2 RT-PCR표체[(9.80±0.78)]균고우N조[(1.90±1.02)]화PMD조[(7.90±0.62)] (F =45.891,P<0.05).(6)PM조폐조직명효매활성측정[(4.89±0.29) ×103]균고우N조[(1.52±0.31) ×103]화PMD조[(2.87.±0.17) ×103](F=47.659,P<0.05).결론 소제량다서배소능유효강저효원매재폐조직중적표체급활성,종이감경실험성대서폐동맥중구,병강저기폐동맥압력.기궤제가능여강저폐동맥관벽세포증식병유도증생세포조망、한제폐동맥평활기세포천이유관.해연구위금후소제량다서배소작위금속기질단백매억제제용우폐동맥고압적치료제공료삼고의거.
Objective To investigate the effects of low-dose doxycycline on the development of monocrotaline-induced pulmonary hypertension and pulmonary arterial remodeling in left-pneumonectomized rats.Methods 45 healthy male SD rats were randomly divided into the three groups:normal control group (N),model group (PM) and doxycycline intervention group (PMD),each group with 15 cases.After five weeks,the rats were sacrifised to record the pulmonary arterial pressure(PAP) and measure the fulton index immediately.Histological and morphometric analysis were used to determine percent arterial wall thickness,muscularizition of non-musclarised peripheral pulmonary arterioles and neointima formation microscopically.Immunohistochemical stains of PCNA and Caspases-3 were used to investigate cellular proliferation and apoptosis,respectively.Expression of MMP-2,MMP-9 and TIMP-1 were assessed by both immunohistochemical stain and RT-PCR of relevant mRNAs.Meanwhile,the activity of MMPs was measured by gelatin zymography in the lung tissue.Results (1) Rats in PM group showed that mPAP obviously increased comparison with their PMD group and N group [PM group (38.89 ± 1.68)mmHg,PMD group (29.89 ± 1.75) mmHg,N group (18.28 ± 1.52) mmHg,F =79.246,P < 0.05].(2) The percent arterial wall thickness were significantly raised in PM group compared with PMD group and N group [PM group (51.98 ± 8.49)%,PMD group (26.19 ± 3.10) %,N group (10.97 ± 3.22) %,F =58.439,P < 0.05].(3) The expression of Caspases-3 was decreased in PM group compared to the PMD group significantly[PM group (14.38 ±2.60) × 103,PMD group (25.81 ± 6.14) × 103,N group (5.29 ± 1.39) × 103,F =58.421,P < 0.05].(4) Neointima was observed in PM group [(75.69 ± 3.98) %] and PMD group[(30.38 ± 5.22)%].Rats in group PM demonstrated more severe neointima hyperplasia than the group PMD (t =10.236,P < 0.05),N group had no new neointima formation.(5)The expression of TIMP-1 in the lung tissue were higher in PM group compared with PMD group and N group(P <0.05),and the expression of MMP-2 in the lung tissue were higher in PM group[(59.61 ± 13.01) × 103] compared with PMD group[(25.95.±6.89) × 103] and N group [(3.78 ± 2.18) × 103] as assessed by both the immunohistochemical stain and RT-PCR (F =76.484,P < 0.05);The expression of MMP-2 by RT-PCR in PM group [(9.80 ± 0.78)] were higher than PMD group[(7.90 ±0.62)] and N group[(1.90 ± 1.02)] (F =45.891,P < 0.05).(6) The activity of MMPs were inhibited by doxycycline effectively as assessed by gelatin zymography [PM group (4.89 ± 0.29) × 103,PMD group (2.87.± 0.17) ×l03,N group(1.52 ±0.31) ×103,F=47.659,P<0.05].Conclusion Low-dose doxycycline attenuated pulmonary arterial remodeling in left-pneumonectomized rats which suffered from monocrotaline-injection simultaneously.The underlying mechanism of that is possiblly ascribled to the reduced VSMCs proliferation,suppress migration and promote cell apoptosis,which are thought to be associated to the inhibition of MMPs by the drug.These results provide using low-dose doxycycline as a new therapeutic strategy for the PAH in the future.